Sage Journals: Discover world-class research

Abstract

Background

Reports on fatty acids levels in multiple sclerosis remain inconclusive.

Objective

To determine the erythrocyte membrane fatty acid levels in multiple sclerosis patients and correlate with Kurtzke Expanded Disability Status Scale.

Methods

Fatty acid composition of 31 multiple sclerosis and 30 control individuals were measured by gas chromatography.

Results

The membrane phosphatidylcholine C20:4n – 6 concentration was lower in the multiple sclerosis patients when compared to that of the control group, P = 0.04 and it correlated inversely with the EDSS and FSS.

Conclusion

Decrease in C20:4n – 6 in the erythrocyte membrane could be an indication of depleted plasma stores, and a reflection of disease severity.

Keywords

multiple sclerosis outcome measurement relapsing/remitting

Get full access to this article

View all access options for this article.

References

1 Koch M Ramsaransing GSM Fokkema MR Heersema DJ De Keyser J . Erythrocyte membrane fatty acids in benign and progressive forms of multiple sclerosis. J Neurol Sci 2006; 244: 123–126.

2 Navarro X Segura R . Red blood cell fatty acids in multiple sclerosis. Acta Neurol Scand 1989; 79: 32–37.

3 Harbige LS Sharief MK . Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis. Br J Nutr 2007; 98: S46–S53.

4 Kurtzke JF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452.

5 Folch J Lees M Sloane-Stanley GH . A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497–509.

6 Van Jaarsveld PJ Smuts CM Tichelaar HY Kruger M Benadé AJS . Effect of palm oil on plasma lipoprotein concentrations and plasma low-density lipoprotein composition in non-human primates. Int J Food Sci Nutr 2000; 51: S21–S30.

7 Williams EE . Membrane lipids: what membrane physical properties are conserved during physiochemically-induced membrane restructuring? Am Zool 1998; 38: 280–290.

8 Homa ST Belin J Smith AD Monro JA Zilkha KJ . Levels of linoleate and arachidonate in red blood cells of healthy individuals and patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 1980; 43: 106–110.

9 Baker RWR Thompson RHS Zilkha KJ . Serum fatty acids in multiple sclerosis. J Neurol Neurosurg Psychiat 1964; 27: 408–414.

10.

10 Holman RT Johnson SB Kokmen E . Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis. Proc Natl Acad Sci USA 1989; 86: 4720–4724.

11.

11 Horrobin DF . The phospholipid concept of psychiatric disorders and its relationship to the neurodevelopmental concept of schizophrenia. In: M Peet I Glen DF Horrobin , (eds), Phospholipid spectrum disorder in psychiatry, ch. 1. Lancashire, UK: Marius Press; 1999. p. 3–16.

12.

12 Carlson SE Carver JD House SC . High fat diets varying in ratios of polyunsaturated to saturated fatty acid and linoleic to linolenic acid: a comparison of rat neural and red cell membrane phospholipids. J Nutr 1986; 116: 718–725.

13.

13 Piomelli D . Arachidonic acid. Psychopharmacology: 4th Generation of Progress. Eds, Bloom, E, Kupfer, J, Part 1. New York, USA: Raven Press, (2000) http://www.acnp.org/ (accessed 13.11.08).

Erythrocyte membrane fatty acids in patients with multiple sclerosis

Abstract

Keywords

Get full access to this article

References